|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
PROGRAMME -
CONGRESS DAY 1: 1 September 2023 |
|
|
|
|
|
|
|
|
|
|
|
| Session
1 |
|
09:00 - 11:05 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Friday,
01 Sep 2023 |
|
Chairperson |
|
Dr Karmani Chetty |
|
|
|
|
|
|
|
09:00 - 09:10 |
|
Opening and Welcome |
Dr
Karmani Chetty; NHLS, South Africa (Session Chair) |
Abbreviations |
|
|
09:10 -
09:30 |
|
Driving Innovation and Excellence in South African Pathology
Services |
Prof. Eric Buch; NHLS, South Africa |
LSHTM - London School of Hygeine & Tropical Medicine |
|
09:30 -
10:00 |
|
Unlocking the African Genomes for Precision Medicine |
Prof. Segun Fatumo; MRC/AVRI & LSHTM, Uganda |
MRC/UVRI - Medical Research Council/Uganda Virus Research
Institute |
|
10:00 -
10:30 |
|
Metagenomics: Advancing Precision Medicine |
Prof. Judith Breuer; UCL, United Kingdom |
NDoH - National Department of Health |
|
|
10:30 -
11:00 |
|
Empowering South Africa's Healthcare: The Pivotal Role of Pathology in Shaping a Resilient and
Equitable Future (Keynote Address) |
Minister
of Health; NDOH, South Africa |
NHLS - National Health Laboratory Service |
|
11:00 -
11:05 |
|
Closing |
|
UCL - University College London |
|
| |
|
|
|
|
|
|
|
|
|
|
| |
|
11: 05 -11:30 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Session
2 |
|
11:30 - 13:00 |
|
ANATOMICAL PATHOLOGY
(Venue: Kwa-Thema) |
CHEMICAL
PATHOLOGY
(Venue: Ekurhuleni 4) |
HAEMATOLOGY
(Venue: Tembisa) |
HUMAN
GENETICS
(Venue: Daveyton) |
MEDICAL
MICROBIOLOGY
(Venue: Ekurhuleni 5) |
MEDICAL
VIROLOGY
(Venue: Private Dining) |
PUBLIC
HEALTH
(Venue: Duduza) |
| |
|
Scientific Tracks |
|
Neuropathology |
Good Laboratory Practice and Laboratory Methods |
HIV Haematology |
Human Genetics |
Cutting-edge Diagnostics in Managing Mycobacteria |
Respiratory Infections |
Session Theme |
| |
|
Chairpersons |
|
Dr
Sugeshnee Pather |
Prof Nigel Crowther |
Dr Ravnit Grewal |
Prof Raj Ramesar |
Mr Yonas Ghebrekristos
Dr Stefan Opperman |
Prof Raveen Parboosing |
Prof Muzimkhulu Zungu |
| |
|
11:30 - 13:00 |
|
|
Chairpersons Remarks
Good laboratory practice – lessons from
COVID
Prof Makunike Mutasa
AUDIT OF SERUM FREE LIGHT CHAIN TESTING IN
SCREENING FOR MONOCLONAL GAMMOPATHIES
Dr R Banderker
(Abstract No: PRC23-212)
COMPARISON OF THERAPEUTIC AND TOXIC DRUG
LEVELS IN CANDIDATE BLOOD COLLECTION TUBES
Dr A Khine
(Abstract No: PRC23-227)
EVALUATION OF A NOVEL NON-COMMUNICABLE
DISEASE (NCD) POINT-OF-CARE ASSAY IN PARALLEL WITH STANDARD LABORATORY-BASED
GENOTYPING IN POSTMENOPAUSAL BREAST CANCER PATIENTS
Ms K Moremi
(Abstract No: PRC23-1028)
LABORATORY SCREENING OF PORPHYRIAS USING HPLC WITH A FLUORESCENCE
DETECTOR
Mrs Z Magudzu
(Abstract No: PRC23-1267) |
Chairpersons Remarks
Talk Title
Prof Fromm
Talk Title
Dr Nadine Rapiti
Talk Title
Susan Louw
THE DIAGNOSIS AND MANAGEMENT OF HIV ASSOCIATED ACQUIRED HAEMOPHILIA A: A
CASE SERIES FROM DURBAN, SOUTH AFRICA
Dr D Pillay
(Abstract No: PRC23-196)
THE PROGNOSTIC IMPACT OF
IMMUNE-DERANGEMENTS IN HIV-ASSOCIATED DIFFUSE LARGE B-CELL LYMPHOMA
Dr J Vaughan
(Abstract: PRC23-414)
THE ROLE OF SPECIFIC ADHESINS IN THE
REGULATION OF OTHER ADHESIN GENES ASSOCIATED WITH THE PATHOGENICITY OF
MYCOBACTERIUM TUBERCULOSIS
Mr J Mthembu
(Abstract No: PRC23-355)
PERIPHERAL BLOOD CYTOPENIA, AN EARLY
INDICATOR OF INBORN ERRORS OF IMMUNITY
Dr H Cornelissen
(Abstract No: PRC23-199) |
Chairpersons Remarks
Precision Molecular Cytogenetics – a Time to Sequence
Prof Cynthia Morton
Structural and Copy Number Variation resolved using Optical Genome
Mapping
Prof Brynn Levy
Role of the lab in the invasive prenatal testing for foetal genetic
disease
Dr Simpiwe Mose
Genomics of Developmental Delay Disorders
Prof Amanda Krause
A National Vision for Managing Familial Cancers – in the footsteps of the
National Cancer Registry
Prof Raj Ramesar
Innovation in diagnostics: translating population risk into personal
utility using point of care genomics and next generation sequencing
Prof Maritha Kotze
Training imperatives in Human Genetics: a NHLS /University/ /HPCSA
perspective
Prof Magda Theron |
Chairpersons Remarks
Doing better with what we have already:
improving the efficiency of
tuberculosis confirmatory and drug susceptibility testing through
novel triage strategies.
Prof Grant Theron (US)
Comprehensive genetic drug susceptibility
testing within the routine standard of care
Prof Rob Warren (US)
Something from nothing: Sensitivity and
specificity of Xpert MTB/RIF Ultra on contaminated liquid cultures for
tuberculosis and rifampicin-resistance detection
Dr Yonas Ghebrekristos
(Abstract No: PRC23-428)
Xpert MTB/XDR assay - considerations for
implementation at scale
Dr Pedro da Silva (Wits)
Non-Tuberculosis Mycobacteria: Finding the
black cat in the dark room
Dr Stefan Opperman (NHLS Greenpoint TB laboratory)
Q&A
|
Chairpersons Remarks
Talk Title
Dr Kerrigan McCarthy
IMPACT OF INTRA-HOST IMMUNE ADAPTATIONS ON
THE EVOLUTION OF SARS-COV-2 S PROTEIN AMONG INDIVIDUALS WITH SARS-COV-2
INFECTIONS IN SOUTH AFRICA
Mrs K Subramoney
(Abstract No: PRC23-213)
INVESTIGATION OF HIGHLY SYMPTOMATIC
COVID-NEGATIVE SPECIMENS FOR IDENTIFICATION OF RESPIRATORY PATHOGENS
Miss A Mdunyelwa
(Abstract No: PRC23-216)
MAPPING THE TEMPORAL-SPATIAL DISTRIBUTION
OF THE KWAZULU-NATAL SARS-COV-2 EPIDEMIC: MAY 2020-SEPTEMBER 2021; FROM THE
FIRST TO THE THIRD WAVE
Dr C Naicker
(Abstract No: PRC23-1281)
ASSOCIATION BETWEEN SARS-COV-2-SPECIFIC
GENE CYCLE THRESHOLD VALUES AND CLINICAL OUTCOMES OF HOSPITALIZED CASES IN
GAUTENG PROVINCE, SOUTH AFRICA, 2020-2022
Dr M Sikhosana
(Abstract No: PRC23-270)
Q&A
Sprint Presentations |
Chairpersons Remarks
Social and environmental determinants of
health
Dr Mphatso Kamndaya
Abstracts to follow |
Friday
01 Sep 2023 |
|
11:30 - 11:35 |
|
Chairperson's
Remarks
11:30 - 11:35 |
Chairperson's Remarks
11:30 - 11:35 |
Chairperson's Remarks
11:30 - 11:35 |
Chairperson's Remarks
11:30 - 11:35 |
Chairperson's Remarks
11:30 - 11:35 |
Chairperson's Remarks
11:30 - 11:35 |
Chairperson's Remarks
11:30 - 11:35 |
|
11:35 -
11:40 |
|
Case
presentations in paediatric neuropathology
Dr Dan Zaharie
11:35 - 12:00 |
Lessons learned from COVID: the Zimbabwean
experience
Prof Rudo Makunike-Mutasa
11:35 - 12:20 |
Characterization
of HIV-Associated Lymphoma by Flow Cytometry: A case based approach
Prof JR Fromm
11:35 - 11:55 |
Genomics of Developmental Delay Disorders
Prof Amanda Krause
11:35 - 12:10 |
Doing
better with what we have already: improving the efficiency of tuberculosis confirmatory and drug
susceptibility testing through novel triage strategies.
Prof Grant Theron (US)
11:35 - 11:50 |
Wastewater-based
epidemiology for public health surveillance
Dr Kerrigan McCarthy
11:35 - 11:50 |
Social and environmental determinants of
health
Dr Wells Utembe
11:35 - 12:00 |
|
11:40 -
11:45 |
|
|
11:45 -
11:50 |
|
|
11:50 -
11:55 |
|
Comprehensive
genetic drug susceptibility testing within the routine standard of care
Prof Rob Warren (US)
11:50 - 12:05 |
IMPACT
OF INTRA-HOST IMMUNE ADAPTATIONS ON THE EVOLUTION OF SARS-COV-2 S PROTEIN
AMONG INDIVIDUALS WITH SARS-COV-2 INFECTIONS IN SOUTH AFRICA
Mrs K Subramoney
(Abstract No: PRC23-213)
11:50 - 12:00 |
|
11:55 -
12:00 |
|
HIV
DLBCL: Any Difference from HIV negative DLBCL?
Dr Nadine Rapiti
11:55 - 12:05 |
|
12:00 -
12:05 |
|
New
tumour entities in paediatric neuropathology
Dr Shivani Singh
12:00 - 12:20 |
INVESTIGATION
OF HIGHLY SYMPTOMATIC COVID-NEGATIVE SPECIMENS FOR IDENTIFICATION OF
RESPIRATORY PATHOGENS
Miss A Mdunyelwa
(Abstract No: PRC23-216)
12:00 - 12:10 |
IMPACT
OF HBA1C MISCLASSIFICATION ON THE RELATIONSHIP BETWEEN HIV AND TYPE 2
DIABETES IN SOUTH AFRICA: A QUANTITATIVE BIAS ANALYSIS
Prof A Brennan
(Abstract No: PRC23-660)
12:00 - 12:10 |
|
12:05 -
12:10 |
|
HIV-associated Thrombotic Thrombocytopenic Purpura (TTP):
are we closer to the answers?
Dr Susan Louw
12:05 - 12:15 |
Something
from nothing: Sensitivity and specificity of Xpert MTB/RIF Ultra on
contaminated liquid cultures for tuberculosis and rifampicin-resistance
detection
Dr Yonas Ghebrekristos
12:05 - 12:20 |
|
12:10 -
12:15 |
|
Role of the lab in the invasive prenatal testing for
foetal genetic disease
Dr Simpiwe Mose
12:10 - 12:45 |
MAPPING
THE TEMPORAL-SPATIAL DISTRIBUTION OF THE KWAZULU-NATAL SARS-COV-2 EPIDEMIC:
MAY 2020-SEPTEMBER 2021; FROM THE FIRST TO THE THIRD WAVE
Dr C Naicker
(Abstract No: PRC23-1281)
12:10 - 12:20 |
THE
ASSOCIATIONS BETWEEN DIETARY PATTERNS AND CARDIOMETABOLIC RISK PROFILE IN
COMMERCIAL TAXI DRIVERS
Ms T Lopes
(Abstract No: PRC23-742)
12:10 - 12:20 |
|
12:15 -
12:20 |
|
THE
DIAGNOSIS AND MANAGEMENT OF HIV ASSOCIATED ACQUIRED HAEMOPHILIA A: A CASE
SERIES FROM DURBAN, SOUTH AFRICA
Dr D Pillay
(Abstract No: PRC23-196)
12:15 - 12:25 |
|
12:20 -
12:25 |
|
My
approach to paediatric intraoperative neuropathological diagnosis
Dr Dawn-Lee van der Byl
12:20 - 12:40 |
AUDIT
OF SERUM FREE LIGHT CHAIN TESTING IN SCREENING FOR MONOCLONAL
GAMMOPATHIES
Dr R Banderker
(Abstract No: PRC23-212)
12:20 - 12:30 |
Xpert
MTB/XDR assay - considerations for implementation at scale
Dr Pedro da Silva
12:20 - 12:35 |
ASSOCIATION
BETWEEN SARS-COV-2-SPECIFIC GENE CYCLE THRESHOLD VALUES AND CLINICAL OUTCOMES
OF HOSPITALIZED CASES IN GAUTENG PROVINCE, SOUTH AFRICA, 2020-2022
Dr M Sikhosana
(Abstract No: PRC23-270)
12:20 - 12:30 |
GAPS
IN THE TYPE 1 DIABETES CARE CASCADE: A NATIONAL PERSPECTIVE USING SOUTH
AFRICA’S NATIONAL HEALTH LABORATORY SERVICE (NHLS) DATABASE
Prof A Brennan
(Abstract No: PRC23-657)
12:20 - 12:30 |
|
12:25 -
12:30 |
|
THE
PROGNOSTIC IMPACT OF IMMUNE-DERANGEMENTS IN HIV-ASSOCIATED DIFFUSE LARGE
B-CELL LYMPHOMA
Dr J Vaughan
(Abstract: PRC23-414)
12:25 - 12:35 |
|
12:30 -
12:35 |
|
COMPARISON
OF THERAPEUTIC AND TOXIC DRUG LEVELS IN CANDIDATE BLOOD COLLECTION
TUBES
Dr A Khine
(Abstract No: PRC23-227)
12:30 - 12:40 |
Q
& A
12:30 - 12:40 |
QUANTIFYING
OVERDIAGNOSIS OF DIABETES BY GLYCATED HEMOGLOBIN COMPARED TO PLASMA
GLUCOSE-BASED TESTS STRATIFIED BY HIV STATUS
Prof A Brennan
(Abstract No: PRC23-1302)
12:30 - 12:40 |
|
12:35 -
12:40 |
|
Use of NGS in haemolytic anaemias
Prof. Nazeer Alli
12:35 - 12:55 |
Non-Tuberculosis
Mycobacteria: Finding the black cat in the dark room
Dr Stefan Opperman
12:35 - 12:50 |
|
12:40 -
12:45 |
|
Panel
Discussion on Neuropathology
Dr Dan Zaharie, Dr Shivani Singh, Dr
Dawn-Lee van der Byl
12:40 - 13:00 |
EVALUATION
OF A NOVEL NON-COMMUNICABLE DISEASE (NCD) POINT-OF-CARE ASSAY IN PARALLEL
WITH STANDARD LABORATORY-BASED GENOTYPING IN POSTMENOPAUSAL BREAST CANCER
PATIENTS
Ms K Moremi
(Abstract No: PRC23-1028)
12:40 - 12:50 |
Sprint
Presentations
12:40 - 13:00 |
UPTAKE
OF VIRAL LOAD TESTING AND VIRAEMIC EPISODES DURING PREGNANCY
Mrs N Jinga
(Abstract No: PRC23-925)
12:40 - 12:50 |
|
12:45 -
12:50 |
|
GENETICS OF COMPLEX EPILEPSIES IN SOUTH AFRICAN CHILDREN –
PRECISION MEDICINE IN A RESOURCE-CONSTRAINED SETTING
Dr A Esterhuizen
(Abstract No: PRC23-354)
12:45 - 13:00 |
|
12:50 -
12:55 |
|
LABORATORY
SCREENING OF PORPHYRIAS USING HPLC WITH A FLUORESCENCE DETECTOR
Mrs Z Magadzu
(Abstract No: PRC23-1267)
12:50 - 13:00 |
12h50
- 13h00 Q&A |
UNDERSTANDING
ENGAGEMENT IN HIV CARE AMONG PREGNANT WOMEN ACCESSING ANTENATAL SERVICES IN
JOHANNESBURG, SOUTH AFRICA
Mr C Nattey
(Abstract No: PRC23-661)
12:50 - 13:00 |
|
12:55 -
13:00 |
|
Q&A
12:55 - 13:00 |
| |
|
|
|
|
|
|
|
|
|
|
| |
|
13:00 - 13:45 |
|
LUNCH AND NETWORKING |
E-POSTER VIEWING |
Special Chemical Pathology Session:
Exam session with Prof A Zemlin |
|
|
|
|
|
|
|
|
|
|
|
| Session
3 |
|
13:45 - 16:00 |
|
ANATOMICAL PATHOLOGY
(Venue: Kwa-Thema) |
CHEMICAL
PATHOLOGY
(Venue: Ekurhuleni 4) |
HAEMATOLOGY
(Venue: Tembisa) |
HUMAN
GENETICS
(Venue: Daveyton) |
MEDICAL
MICROBIOLOGY
(Venue: Ekurhuleni 5) |
IMMUNOLOGY
(Venue: Thokoza) |
PUBLIC
HEALTH
(Venue: Duduza) |
Friday
01 Sep 2023 |
|
Scientific Tracks |
|
Scientific
Abstracts |
Disease Diagnosis: Questions & Answers |
Classification of Haematolymphoid Malignancies |
Human Genetics |
Investigating TB - The Next Frontier |
Immunolomics |
Session Theme |
|
Chairpersons |
|
Prof A
Afrogheh |
Ms Kelebogile Moremi |
Prof Zivanai Chapanduka |
Dr Nerina van der Merwe |
Mr Yonas Ghebrekristos
Dr Stefan Opperman |
Prof Elizabeth Mayne |
Dr Nonhlanhla Tlotleng |
|
13:45 - 16:00 |
|
Chairpersons
Remarks
Head and Neck Pathology
Prof P Sadow
PLACENTAL MESENCHYMAL DYSPLASIA: AN ODE TO
PLACENTAL "GRAPES"
Dr T Bagratee
(Abstract No: PRC23-581)
AN EVALUATION OF HIGH-RISK HUMAN
PAPILLOMAVIRUS IN SQUAMOUS CELL CARCINOMAS OF THE LIP IN A SOUTH AFRICAN
COHORT
Dr S Harbor
(Abstract No: PRC23-662)
CYTOLOGY AND HISTOLOGY CORRELATION ON ALL
LYMPH NODES ASPIRATED IN THE FINE NEEDLE ASPIRATION (FNA) CLINIC AT GROOTE
SCHUUR HOSPITAL
Dr MJ Chokoe-Maluleke
(Abstract No: PRC23-927)
INTRODUCING A MINIMUM DATASET FOR
COLORECTAL CANCER PATHOLOGY REPORTING IN THE NATIONAL HEALTH LABORATORY
SERVICE
Dr A van Wyk
(Abstract No: PRC23-1045)
PLACENTA ACCRETA SPECTRUM: DIAGNOSIS,
GRADING AND CHALLENGES
Mr P Moodley
(Abstract No: PRC23-1091)
FUNCTIONAL GENOMICS – SINGLE CELL
SEQUENCING AND SPATIAL TRANSCRIPTOMICS AND ITS APPLICATION IN MOLECULAR
PATHOLOGY AND CANCER DIAGNOSTICS
Prof R Naidoo
(Abstract No: PRC23-1270)
MOLECULAR PHENOTYPE OF INVASIVE BREAST
CARCINOMA. A HISTOPATHOLOGICAL STUDY FROM AN ACADEMIC INSTITUTION IN
GA-RANKUWA, GAUTENG, SOUTH AFRICA
Dr M Khaba
(Abstract No: PRC23-1749) |
Chairpersons Remarks
Sprint Presentations
Talk Title
Invited Speaker
HYPERPARATHYROIDISM-JAW TUMOUR SYNDROME:
AN UNFORESEEN DIAGNOSIS
Dr A Zama
(Abstract No: PRC23-257)
MAJOR PATHOGENIC CYP21A2 DELETION
(ABSTRACT NO: PRESENTING WITH CLASSIC SEVERE SALT-WASTING SYNDROME
Dr T Satekge
(Abstract No: PRC23-298)
A DIFFERENT TYPE OF POETRY
Dr J Grove
(Abstract No: PRC23-517)
PINEAL GLAND GERMINOMA IN A 13-YEAR-OLD MALE FROM SOUTH AFRICA AND THE USE
OF ROUTINE BIOCHEMISTRY TESTS IN CEREBROSPINAL FLUID
Dr A Davids
(Abstract No: PRC23-592)
A RARE CASE OF THYROID HORMONE RESISTANCE
SYNDROME
Dr M Dintshi
(Abstract No: PRC23-663)
AN ACUTE ATTACK OF POSTPARTUM PORPHYRIA VARIEGATA TRIGGERED BY
HAEMORRHAGE
Mr E Madingwana
(Abstract No: PRC23-1035)
RARE (ABSTRACT NO: PRESENTATION OF EARLY-ONSET ORNITHINE TRANSCARBAMYLASE
DEFICIENCY IN A FEMALE WITH LYONIZATION: A CASE REPORT
Dr R Singh-Gansan
(Abstract No: PRC23-1314) |
Chairpersons
Remarks
ICC mature LPDs
Prof Elias Campo
WHOv5 Lymphomas
Prof German Ott
10-minutes Q & A
Is morphology still relevant?
Dr Sharon Officer
Approach to cytopenias
Invited Speaker
Case Presentation UKZN
Invited Speaker
Case presentation UCT
Invited Speaker
Case presentation Lancet
Invited Speaker
ACUTE PROMYELOCYTIC LEUKAEMIA: A CENTRAL
SOUTH AFRICAN EXPERIENCE
Dr A van Marle
(Abstract No: PRC23-274)
CHRONIC MYELOID LEUKEMIA KINASE DOMAIN
MUTATIONS: THE THERAPEUTIC AND PROGNOSTIC SIGNIFICANCE IN PATIENTS AT KING
EDWARD VIII HOSPITAL, KWAZULU-NATAL
Dr C Benjamin
(Abstract No: PRC23-179)
EPIDEMIOLOGY OF ADULT T-CELL
LEUKAEMIA/LYMPHOMA IN SOUTH AFRICA OVER A 10-YEAR PERIOD
Dr E Nel
(Abstract No: PRC23-187)
TP53 MUTATIONS IN HAEMATOLOGICAL
MALIGNANCIES: A CENTRAL SOUTH AFRICAN EXPERIENCE
Mr J Kloppers
(Abstract No: PRC23-194)
THE MUTATIONAL LANDSCAPE OF PHILADELPHIA
CHROMOSOME-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS IN THE WESTERN CAPE
PROVINCE, SOUTH AFRICA
Dr M Dicks
(Abstract No: PRC23-1402) |
Chairpersons
Remarks
Precision Molecular Cytogenetics – a Time
to Sequence
Prof Cynthia Morton
Structural and Copy Number Variation
resolved using Optical Genome Mapping
Prof Brynn Levy
Role of the lab in the invasive prenatal
testing for foetal genetic disease
Dr Simpiwe Mose
Genomics of Developmental Delay Disorders
Prof Amanda Krause
A National Vision for Managing Familial
Cancers – in the footsteps of the National Cancer Registry
Prof Raj Ramesar
Innovation in diagnostics: translating
population risk into personal utility using point of care genomics and next
generation sequencing
Prof Maritha Kotze
Training imperatives in Human Genetics: a
NHLS /University/ /HPCSA perspective
Prof Magda Theron |
Chairpersons
Remarks
Advances in TB detection and drug
resistance prediction since the game-changing GeneXpert
Dr Shaheed Omar (NICD)
Developing a new, rapid diagnostic test for
extra-pulmonary Tuberculosis
Dr Ali Ismail (UCT)
A mycobacterial lung challenge model to
study TB immunopathogenesis in humans
Dr Pooran (UCT)
Abstracts
14h45-14h55
14h55-15h05
15h05-15h15
15h15-15h25
15h25-15h35
15h35-15h45
15h45-16h00 Q&A
|
|
Chairpersons Remarks
National Public Health Institutes and the
opportunities and challenges for SA
Dr Atiya Mosam
Notifiable Medical Conditions (NMC)
Surveillance Systems
Dr Harsha Somaroo
Abstracts to follow |
|
13:45 - 13:50 |
|
Chairperson's
Remarks
13:45 - 13:50 |
Chairperson's
Remarks
13:45 - 13:50 |
Chairperson's
Remarks
13:45 - 13:50 |
Chairperson's
Remarks
13:45 - 13:50 |
Chairperson's
Remarks
13:45 - 13:50 |
Chairperson's
Remarks
13:45 - 13:50 |
Chairperson's Remarks
13:45 - 13:50 |
|
13:50 -
13:55 |
|
Head
and Neck Pathology
Prof P Sadow
13:50 - 14:30 |
Debate: To HbA1c or not to
HbA1c?
Prof J George & Prof A Zemlin
Chair: Prof N Crowther
13:50 - 14:30 |
ICC
mature LPDs
Prof Elias Campo
13:50 - 14:15 |
Innovation
in diagnostics: translating population risk into personal utility using point
of care genomics and next generation sequencing
(Abstract No: PRC23-1079)
Prof Maritha Kotze
13:50 - 14:20 |
Advances
in TB detection and drug resistance prediction since the game-changing
GeneXpert
Dr Shaheed Omar (NICD)
13:50 - 14:05 |
Obesity
Dr Melin Ambele
13:50 - 14:10 |
Landscape of Occupational Health in Southern
Africa
Prof Dingani Moyo
13:50 - 14:15 |
|
13:55 -
14:00 |
|
|
14:00 -
14:05 |
|
|
14:05 -
14:10 |
|
Developing
a new, rapid diagnostic test for extra-pulmonary Tuberculosis
Dr Ali Ismail (UCT)
14:05 - 14:20 |
|
14:10 -
14:15 |
|
Metabolomics
of mucosal surfaces
Dr Jo-Anne Passmore
14:10 - 14:30 |
|
14:15 -
14:20 |
|
WHOv5
Lymphomas
Prof German Ott
14:15 - 14:40 |
Notifiable Medical Conditions (NMC) Surveillance
Systems
Ms Mabore Morifi
14:15 - 14:40 |
|
14:20 -
14:25 |
|
DIAGNOSTIC
NEXT GENERATION SEQUENCING: REVIEWING AND UPDATING 500 GENE PANEL TARGETING
INHERITED DISEASE
Dr M Mudau
(Abstract No: PRC23-590)
14:20 - 14:40 |
A
mycobacterial lung challenge model to study TB immunopathogenesis in
humans
Dr Anil Pooran (UCT)
14:20 - 14:35 |
|
14:25 -
14:30 |
|
|
14:30 -
14:35 |
|
PLACENTAL
MESENCHYMAL DYSPLASIA: AN ODE TO PLACENTAL "GRAPES”
Dr T Bagratee
(Abstract No: PRC23-581)
14:30 - 14:45 |
HYPERPARATHYROIDISM-JAW
TUMOUR SYNDROME: AN UNFORESEEN DIAGNOSIS
Dr A Zama
(Abstract No: PRC23-257)
14:30 - 14:40 |
Next
Generation Single cell analysis
Dr Catherina Worsley
14:30 - 14:50 |
|
14:35 -
14:40 |
|
Q&A
14:35 - 14:40 |
|
14:40 -
14:45 |
|
MAJOR
PATHOGENIC CYP21A2 DELETION (ABSTRACT NO: PRESENTING WITH CLASSIC SEVERE
SALT-WASTING SYNDROME
Dr T Satekge
(Abstract No: PRC23-298)
14:40 - 14:50 |
Approach
to cytopenias
Dr Sharon Officer
14:40 - 14:50 |
FLUORESCENCE IN SITU HYBRIDISATION FINDINGS IN MULTIPLE
MYELOMA SAMPLES REFERRED TO THE NATIONAL HEALTH LABORATORY SERVICE
CYTOGENETICS LABORATORY, CAPE TOWN
Mr R Jacocbs
(Abstract No: PRC23-1096)
14:40 - 14:50 |
EVALUATION
OF THE SUITABILITY OF SIX NUCLEIC ACID EXTRACTION METHODS FOR MYCOBACTERIUM
TUBERCULOSIS GENOMIC SEQUENCING
Miss M MUTHANYI
(Abstract No: PRC23-356)
14:40 - 14:50 |
NATIONAL HEALTH LABORATORY SERVICE MPOX SURVEILLANCE,
SOUTH AFRICA, MAY 2022-MARCH 2023
Dr V Msimang
(Abstract No: PRC23-430)
14:40 - 14:50 |
|
14:45 -
14:50 |
|
AN
EVALUATION OF HIGH-RISK HUMAN PAPILLOMAVIRUS IN SQUAMOUS CELL CARCINOMAS OF
THE LIP IN A SOUTH AFRICAN COHORT
Dr S Harbor
(Abstract No: PRC23-662)
14:45 - 15:00
|
|
14:50 -
14:55 |
|
A
DIFFERENT TYPE OF POETRY
Dr J Grove
(Abstract No: PRC23-517)
14:50 - 15:00 |
Case presentation UCT
Dr Lauren Lemkus
14:50 - 15:00 |
CREATING A POPULATION SPECIFIC HAPLOTYPE FREQUENCY
DATABASE WITH MUTATION FREQUENCIES USING THE X-CHROMOSOME STR MULTIPLEX
Ms S Maharaj
(Abstract No: PRC23-946)
14:50 - 15:00 |
XPERT
MTB/RIF ULTRA ON CONTAMINATED LIQUID CULTURES TO IDENTIFY TUBERCULOSIS AND
RIFAMPICIN-RESISTANCE AND REDUCE LOSS-TO-FOLLOW-UP
Miss N Mhlambi
(Abstract No: PRC23-865)
14:50 - 15:00 |
Proteomics in Autoimmunity
Prof Pieter Meyer
14:50 - 15:00 |
TRENDS IN GERMS-SA
LABORATORY-BASED SURVEILLANCE PROGRAMME SUBMISSION AND VIABILITY OF ISOLATES
FROM NATIONAL HEALTH LABORATORY SERVICES MICROBIOLOGY LABORATORIES FROM
2018-2022
Ms M Manaka
(Abstract No: PRC23-516)
15:00 - 15:10 |
|
14:55 -
15:00 |
|
|
15:00 -
15:05 |
|
CYTOLOGY
AND HISTOLOGY CORRELATION ON ALL LYMPH NODES ASPIRATED IN THE FINE NEEDLE
ASPIRATION (FNA) CLINIC AT GROOTE SCHUUR HOSPITAL
Dr MJ Chokoe-Maluleke
(Abstract No: PRC23-927)
15:00 - 15:15 |
PINEAL
GLAND GERMINOMA IN A 13-YEAR-OLD MALE FROM SOUTH AFRICA AND THE USE OF
ROUTINE BIOCHEMISTRY TESTS IN CEREBROSPINAL FLUID
Dr A Davids
(Abstract No: PRC23-592)
15:00 - 15:10 |
Case
Presentation: A tale of two pathologies… or not?
Dr Tanya De Jager
15:00 - 15:10 |
INVESTIGATION OF CYSTIC FIBROSIS RESEARCH PARTICIPANTS’
UNDERSTANDING OF THE GENETIC NATURE OF THE DISEASE AND THE CONSENT PROCESS
Ms S Mahlaba
(Abstract No: PRC23-190)
15:00 - 15:10 |
TB-SPUTUM
SAMPLE REJECTION IN A HIGH THROUGHPUT LABORATORY: A DESCRIPTIVE STUDY
Miss M Zerbini
(Abstract No: PRC23-947)
15:00 - 15:10 |
PERSISTENCE OF VIRAL SUPPRESSION AMONG PEOPLE IN
SOUTH AFRICA’S PUBLIC SECTOR HIV TREATMENT PROGRAM: A NATIONAL COHORT
STUDY
Ms E Lauren
(Abstract No: PRC23-582)
15:10 - 15:20 |
|
15:05 -
15:10 |
|
|
15:10 -
15:15 |
|
A
RARE CASE OF THYROID HORMONE RESISTANCE SYNDROME
Dr M Dintshi
(Abstract No: PRC23-663)
15:10 - 15:20 |
CHRONIC
MYELOID LEUKEMIA KINASE DOMAIN MUTATIONS: THE THERAPEUTIC AND PROGNOSTIC
SIGNIFICANCE IN PATIENTS AT KING EDWARD VIII HOSPITAL, KWAZULU-NATAL
Dr C Benjamin
(Abstract No: PRC23-179)
15:10 - 15:20 |
EVALUATING THE CLINICAL UTILITY OF A SNP-BASED MICROARRAY
PLATFORM - A COMPARATIVE STUDY
Ms M Mayisela
(Abstract No: PRC23-222)
15:10 - 15:20 |
THE
USE OF BEDAQUILINE IN TREATMENT OF PRE-XDR AND XDR PULMONARY TUBERCULOSIS
PATIENTS IN LIMPOPO PROVINCE
Mr K Kaapu
(Abstract No: PRC23-1099)
15:10 - 15:20 |
Interactive
Discussion and Q&A
15:10 - 15:30 |
TRENDS IN CD4 COUNT TESTING VOLUMES AMONG
PATIENTS PRESENTING FOR HIV CARE IN SOUTH AFRICA
Mr C Nattey
(Abstract No: PRC23-943)
15:20 - 15:30 |
|
15:15 -
15:20 |
|
FUNCTIONAL
GENOMICS – SINGLE CELL SEQUENCING AND SPATIAL TRANSCRIPTOMICS AND ITS
APPLICATION IN MOLECULAR PATHOLOGY AND CANCER DIAGNOSTICS
Prof R Naidoo
(Abstract No: PRC23-1270)
15:15 - 15:30 |
|
15:20 -
15:25 |
|
AN
ACUTE ATTACK OF POSTPARTUM PORPHYRIA VARIEGATA TRIGGERED BY HAEMORRHAGE
Mr E Madingwana
(Abstract No: PRC23-1035)
15:20 - 15:30 |
EPIDEMIOLOGY
OF ADULT T-CELL LEUKAEMIA/LYMPHOMA IN SOUTH AFRICA OVER A 10-YEAR
PERIOD
Dr E Nel
(Abstract No: PRC23-187)
15:20 - 15:30 |
SEX CHROMOSOMES PROBE VALIDATION BETWEEN AGILENT
GENETISURE CYTO CGH 8X60K VS SUREPRINT G3 ISCA V2 CGH 8X60K ARRAYS
Dr T Marutha
(Abstract No: PRC23-231)
15:20 - 15:30 |
A
COMPARISON BETWEEN ROCHE COBAS® MTB, MTB-RIF/INH AND CEPHEID XPERT® MTB/RIF
ULTRA IN A HIGH THROUGHPUT LABORATORY
Mr G Kisten
(Abstract No: PRC23-423)
15:20 - 15:30 |
INCIDENCE OF
CRYPTOCOCCAL DISEASE FROM 2007 THROUGH 2021 IN RELATION TO ANTIRETROVIRAL
UPTAKE IN KWAZULU NATAL, SOUTH AFRICA
Miss W Ngubane
(Abstract No: PRC23-646)
15:30 - 15:40 |
|
15:25 -
15:30 |
|
|
15:30 -
15:35 |
|
PLACENTA
ACCRETA SPECTRUM: DIAGNOSIS, GRADING AND CHALLENGES
Mr P Moodley
(Abstract No: PRC23-1091)
15:30 - 15:45 |
RARE
PRESENTATION OF EARLY-ONSET ORNITHINE TRANSCARBAMYLASE DEFICIENCY IN A FEMALE
WITH LYONIZATION: A CASE REPORT
Dr R Singh-Gansan
(Abstract No: PRC23-1314)
15:30 - 15:40 |
TP53
MUTATIONS IN HAEMATOLOGICAL MALIGNANCIES: A CENTRAL SOUTH AFRICAN
EXPERIENCE
Mr J Kloppers
(Abstract No: PRC23-194)
15:30 - 15:40 |
IMPACT OF VARIANTS IN THE DNA DAMAGE RESPONSE GENES
AFFECTING DOUBLE-STRAND BREAK REPAIR RECOGNITION IN BREAST AND OVARIAN CANCER
PATIENTS
Ms K Ntaita
(Abstract No: PRC23-928)
15:30 - 15:40 |
PERFORMANCE
OF THE GENEXPERT MTB/RIF ULTRA IN EXTRA-PULMONARY SPECIMENS IN THE REFERENCE
LABORATORY IN A HIGH TB BURDENED PROVINCE
Dr V Singh
(Abstract PRC23-653)
15:30 - 15:40 |
CD4
LABORATORY TESTING IN SOUTH AFRICA: TRENDS IN AGE AND GENDER DISTRIBUTION,
2012 AND 2022
Dr L Coetzee
(Abstract No: PRC23-1293)
15:30 - 15:40 |
INSTITUTIONAL BARRIERS
TO EFFECTIVE MUNICIPAL SOLID WASTE MANAGEMENT IN NGAKA MODIRI MOLEMA DISTRICT
MUNICIPALITY, SOUTH AFRICA
Dr W Utembe
(Abstract No: PRC23-650)
15:40 - 15:50 |
|
15:35 -
15:40 |
|
|
15:40 -
15:45 |
|
ASSOCIATION OF HIV-1 NEF POLYMORPHISMS WITH CORONARY
ARTERY DISEASE IN HIV-POSITIVE PATIENTS
Mr O Mannafela
(Abstract No: PRC23-427)
15:40 - 15:50 |
THE
MUTATIONAL LANDSCAPE OF PHILADELPHIA CHROMOSOME-NEGATIVE MYELOPROLIFERATIVE
NEOPLASMS IN THE WESTERN CAPE PROVINCE, SOUTH AFRICA
Dr M Dicks
(Abstract No: PRC23-1402)
15:40 - 15:50 |
A CASE REPORT: A MYELODSPLASTIC SYNDROME CASE WITH
MULTIPLE CHROMOSOMAL ABNORMALITIES, USING CYTOGENETICS AND MOLECULAR
CYTOGENETICS TECHNIQUES
Ms M Notani
(Abstract No: PRC23-930)
15:40 - 15:50 |
15h40
- 16h00 Q&A |
REGULATORS
OF NEUROIMMUNE FUNCTION IN THE MANIFESTATION OF CENTRAL NERVOUS SYSTEM
TUBERCULOSIS IN THE ABSENCE OF MICROGLIA
Miss L Thipane
(Abstract No: PRC23-1334)
15:40 - 15:50 |
Sprint Presentations
12:40 - 13:00 |
|
15:45 -
15:50 |
|
MOLECULAR
PHENOTYPE OF INVASIVE BREAST CARCINOMA. A HISTOPATHOLOGICAL STUDY FROM AN
ACADEMIC INSTITUTION IN GA-RANKUWA, GAUTENG, SOUTH AFRICA
Dr M Khaba
(Abstract No: PRC23-1749)
15:45 - 16:00 |
|
15:50 -
15:55 |
|
Chair: Dr Siphokazi
Gwiliza
Sprint Presentations
15:50 - 16:00 |
FACTOR V LEIDEN (FVL) AND PROTHROMBIN (FII) DIAGNOSTIC
REQUESTS, MOLECULAR TESTING AND PREVALENCE EVALUATION IN HEREDITARY
THROMBOPHILIA AT TYGERBERG HOSPITAL
Dr C Swanepoel
(Abstract No: PRC23-330)
15:50 - 16:00 |
THE CONSTITUTIONAL DER(X)T(X,4): THE MECHANISM RESPONSIBLE
FOR THE GROSS CHROMOSOMAL REARRANGEMENT IDENTIFIED USING CHROMOSOMAL
KARYOTYPING
Ms K Motuba
(Abstract No: PRC23-1146)
15:50 - 16:00 |
INVESTIGATION
OF SARS-COV-2 ANTIBODY DURATION, REINFECTIONS AND BREAKTHROUGH INFECTIONS IN
UNVACCINATED AND VACCINATED INDIVIDUALS IN A RURAL SOUTH AFRICAN
SETTING
Dr C Umunnakwe
(Abstract No: PRC23-1398)
15:50 - 16:00 |
|
15:55 -
16:00 |
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
16:00 - 16:15 |
|
TEA BREAK AND NETWORKING |
|
|
|
|
|
|
|
|
|
|
|
| Session
4 |
|
16:15 - 18:00 |
|
Poster Viewing
and Presentation Session |
Intern Medical Scientists Trainee Platform
Venue: Ekurhuleni 5 |
|
|
|
|
|
|
|
|
|
|
|